Mortality in Women across the FMR1 CGG Repeat Range: The Neuroprotective Effect of Higher Education

Cells. 2023 Aug 24;12(17):2137. doi: 10.3390/cells12172137.

Abstract

Higher education has been shown to have neuroprotective effects, reducing the risk of Alzheimer's and Parkinson's diseases, slowing the rate of age-related cognitive decline, and is associated with lower rates of early mortality. In the present study, the association between higher education, fragile X messenger ribonucleoprotein 1 (FMR1) cytosine-guanine-guanine (CGG) repeat number, and mortality before life expectancy was investigated in a population cohort of women born in 1939. The findings revealed a significant interaction between years of higher education and CGG repeat number. Counter to the study's hypothesis, the effects of higher education became more pronounced as the number of CGG repeats increased. There was no effect of years of higher education on early mortality for women who had 25 repeats, while each year of higher education decreased the hazard of early mortality by 8% for women who had 30 repeats. For women with 41 repeats, the hazard was decreased by 14% for each additional year of higher education. The interaction remained significant after controlling for IQ and family socioeconomic status (SES) measured during high school, as well as factors measured during adulthood (family, psychosocial, health, and financial factors). The results are interpreted in the context of differential sensitivity to the environment, a conceptualization that posits that some people are more reactive to both negative and positive environmental conditions. Expansions in CGG repeats have been shown in previous FMR1 research to manifest such a differential sensitivity pattern.

Keywords: FMR1 CGG repeats; differential sensitivity; higher education; mortality.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged, 80 and over
  • Cognitive Dysfunction*
  • Cytosine
  • Female
  • Fragile X Mental Retardation Protein / genetics
  • Guanine
  • Humans
  • Neuroprotective Agents*
  • Parkinson Disease*

Substances

  • Neuroprotective Agents
  • Cytosine
  • Guanine
  • FMR1 protein, human
  • Fragile X Mental Retardation Protein